EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • March 30th, 2020 • Moderna, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionThis Executive Retention Agreement (this “Agreement”) is entered into effective as of March 29, 2020 (the “Effective Date”) between Tal Zaks, M.D. (the “Executive”) and Moderna, Inc. (the “Company,” together with Executive, the “Parties”).